Clinical Trial Update: Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes

View source ↗

Summary

A completed clinical trial update investigates how immune and metabolic pathways interact in myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Myelodysplastic Syndromes | Status: COMPLETED